Important Industry Notification
As of June 1, 2008, the MacuScope™ instrument from MacuChek, LLC and the MacuHealth/LMZ3 supplement from AdMed, LLC is now exclusively marketed and sold in the US, through Marco Ophthalmic, Inc.
In 2005, Marco entered posterior segment diagnostics with its first device for retinal imaging and structural analysis. Retina was a critical frontier for Marco, in an effort to maintain a preeminent position as 'Leader in Vision Diagnostics'. More important, the commitment to support primary eye care required greater expansion into preventative, health care technologies.
The MacuScope™ and MacuHealth products represent a hopeful future in the fight against AMD and have a unique fit within Marco. These products deserve (and require), a dedicated network of seasoned ophthalmic sales specialists that can deliver the added value of consultation to any practice seeking to provide earliest risk assessment diagnostics for their patients- and to competitively market and grow the practice within their community. Further, Marco shares a 'partnership-for-life' mantra with all of its accounts- the greater Marco Family. This commitment transcends the mere sale of any one device- but rather, lives on through world class training, customer care, and technical support, for the life of the practice.
As an existing MacuChek/AdMed account, you are now an important part of the Marco Family.
We ask that you contact Marco directly for all of your future needs concerning the MacuScope™ and MacuHealth/LMZ3 products. We look forward to a rewarding and long-lasting partnership in the formative years to come.
MacuScope™: this powerful AMD risk-assessment device complements the RTA5 Retinal Thickness Analyzer, and broadens the Marco 'Vision Wellness' platform within the growing Retina Division.
www.marco.com or www.TheDifferenceIsMarco.com
11825 Central Parkway / Jacksonville, FL 32224 / 800.874.5274 or 904.642.9330